Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 699 23 687.8 |
96 | EP file number | EAKZ | 99 93 4914.5 |
86 | WO file number | WAKZ | PCT/GB99/02361 |
97 | EP publication number | EPN | 1098639 |
87 | WO publication number | WPN | 2000004890 |
54 | Designation/title | TI | Verwendung des Verstärkers der Glukoseaufnahme Rosiglitazon zur Verminderung der Ischämie-induzierten Apoptose der pankreatischen Betazellen, der endothelialen Zellen und der neuronalen Zellen |
51 | IPC main class | ICM (ICMV) | A61K 31/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/425 (2006.01), A61K 31/44 (2006.01), A61P 9/10 (2006.01) |
22 | DE application date | DAT | Jul 21, 1999 |
96 | EP application date | EAT | Jul 21, 1999 |
86 | WO application date | WAT | Jul 21, 1999 |
43 | Date of first publication | OT | Feb 3, 2000 |
| Date of publication of grant | PET | Feb 9, 2005 |
71/73 | Applicant/owner | INH | SmithKline Beecham p.l.c., Brentford, Middlesex, GB; Laboratoire GlaxoSmithKline S.A.S., Marly-le-Roi, FR |
72 | Inventor | IN | BRIL M. A., Antoine, Brendford, Middlesex TW8 9GS, GB; BUCKINGHAM Edwin, Robin, Brendford, Middlesex TW8 9GS, GB; KHANDOUDI, Nassirah, Brendford, Middlesex TW8 9GS, FR |
74 | Representative | VTR | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000069923687T2 Searchable text:
DE000069923687T2 |
| Address for service | | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 9815871 Jul 21, 1998
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 9815872 Jul 21, 1998
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 9905387 Mar 9, 1999
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
81 | Designated WO countries | WDS | SI, RO |
| Published EP/WO documents | EPWOPN | Original document:
EP000001098639 Searchable text:
EP000001098639 Original document:
EP000001098639B1 Searchable text:
EP000001098639B1 Original document:
WO002000004890 Searchable text:
WO002000004890 |
43 | Date of first publication | EVT | Feb 3, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 25, 2018 (Show all update days)(Hide all update days)- Oct 25, 2018; Aug 25, 2015; Mar 27, 2015; Jan 23, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 4, 2005 |
71/73 | Applicant/owner | INH | SmithKline Beecham p.l.c., Brentford, Middlesex, GB; Laboratoire GlaxoSmithKline S.A.S., Marly-le-Roi, FR |
71/73 | Previous applicant/owner | INHF | SmithKline Beecham Biologicals S.A., Rixensart, BE, Smithkline Beecham Laboratoires Pharmaceutiques, Nanterre, FR |